caVos Biotherapeutics

📍 Jerusalem, Israel🗓 Founded 2021👥 6 employees💰 Last funded Aug 2024
Biotechnology
LinkedIn
Cavos Biotech is an emerging genomic and data science company focusing on the development of novel drugs based on naturally occurring resistance mechanisms for various diseases. We are developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found in specific, and across various animals. We harness the genomic and data revolution and use high resolution identification methods to uncover existing anti-cancer mechanisms, and novel drug targets, and to revolutionize the way by which drug targets are discovered and identified.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2021
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
3
Investor activity2021–2024 · investors recorded per year
2021120242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in caVos Biotherapeutics?
caVos Biotherapeutics has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did caVos Biotherapeutics last raise funding?
The most recent investment in caVos Biotherapeutics recorded on gritt.io was in August 2024.
When was caVos Biotherapeutics founded?
caVos Biotherapeutics was founded in 2021.
What industry is caVos Biotherapeutics in?
caVos Biotherapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is caVos Biotherapeutics based?
caVos Biotherapeutics is headquartered in Jerusalem, Israel.